Compare SRRK & BZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | BZ |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.4B |
| IPO Year | 2018 | 2021 |
| Metric | SRRK | BZ |
|---|---|---|
| Price | $48.29 | $13.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $56.17 | $23.00 |
| AVG Volume (30 Days) | 1.1M | ★ 3.1M |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 1.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.92 |
| Revenue Next Year | $534.24 | $12.78 |
| P/E Ratio | ★ N/A | $22.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.07 | $12.85 |
| 52 Week High | $51.63 | $25.26 |
| Indicator | SRRK | BZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 40.98 |
| Support Level | $45.28 | $13.02 |
| Resistance Level | $51.34 | $14.81 |
| Average True Range (ATR) | 2.39 | 0.52 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 50.94 | 22.80 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.